Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will present at the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018 at 8:40 a.m. E.T. The conference is being held at the Boston Marriott Copley Place.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180307005296/en/
Contacts:
Investors:
Argot Partners
Natalie
Wildenradt, 646-681-8192
natalie@argotpartners.com
or
Media:
Argot
Partners
David Rosen, 212-600-1902
david.rosen@argotpartners.com